Taysha Gene Therapies, Inc. (TSHA) on GreekSoup https://greeksoup.ai/stocks/us/tsha/ Every dated entry in the public record on Taysha Gene Therapies, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 30 Oct 2026 00:00:00 +0000 Taysha Gene Therapies, Inc.: short interest 51,249,292 shares at the 15 October 2026 settlement, 11.56 days to coverhttps://greeksoup.ai/stocks/us/tsha/short-interest/us:TSHA:short-interest:2026-10-15:f46b8b0ec3Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Taysha Gene Therapies, Inc.: short interest 55,020,663 shares at the 30 September 2026 settlement, 11.15 days to coverhttps://greeksoup.ai/stocks/us/tsha/short-interest/us:TSHA:short-interest:2026-09-30:749721d8aeWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Taysha Gene Therapies, Inc.: short interest 51,405,384 shares at the 15 September 2026 settlement, 18.78 days to coverhttps://greeksoup.ai/stocks/us/tsha/short-interest/us:TSHA:short-interest:2026-09-15:7a7e21ab27Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Taysha Gene Therapies, Inc.: short interest 46,800,424 shares at the 31 August 2026 settlement, 19.40 days to coverhttps://greeksoup.ai/stocks/us/tsha/short-interest/us:TSHA:short-interest:2026-08-31:1919a3470dMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Taysha Gene Therapies, Inc.: Schedule 13G/A filed by RA Capital Management, L.P., 9.9% of the classhttps://greeksoup.ai/stocks/us/tsha/holders/us:TSHA:schedule-13:2026-08-14:fb8bbedf80Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Taysha Gene Therapies, Inc.: short interest 46,738,149 shares at the 14 August 2026 settlement, 17.42 days to coverhttps://greeksoup.ai/stocks/us/tsha/short-interest/us:TSHA:short-interest:2026-08-14:7a006da6aeFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Taysha Gene Therapies, Inc.: Schedule 13G/A filed by Morgan Stanley, 5.1% of the classhttps://greeksoup.ai/stocks/us/tsha/holders/us:TSHA:schedule-13:2026-08-13:1782269e4bThu, 13 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Taysha Gene Therapies, Inc. Q2 FY2026 results: revenue $0, net income -$47 millionhttps://greeksoup.ai/stocks/us/tsha/results/fy2026-q2/us:TSHA:result:2026-08-11:db381ee731Tue, 11 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Taysha Gene Therapies, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/tsha/filings/us:TSHA:filing:2026-08-11:7c4a6dd735Tue, 11 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Taysha Gene Therapies, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/tsha/filings/us:TSHA:filing:2026-08-11:7477c2d976Tue, 11 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>